Products: Xenazine® XENAZINE®: 25 mg, scored tablets Xenazine® is indicated for the treatment of Huntington’s chorea. Xenazine® was developed by Cambridge Laboratories (UK). EUSA holds an exclusive agreement for the distribution of Xenazine® in France where it obtained a marketing authorization in France in July 2005. For information on our products, where they are available and prescribing information, please see the Product Summary table.
|
 |
|
|
| Back to home page | Disclaimer | Legal |
